Form 4: Dyne Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Susanna Gatti High, Chief Operating Officer of Dyne Therapeutics, sold shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 7, 2024, Susanna Gatti High, the Chief Operating Officer of Dyne Therapeutics, sold 1,591 shares of common stock at a price of $25.85 per share.
- The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted on November 15, 2023.
- The sale was part of a pre-arranged plan under Rule 10b5-1(c).
- Following the transaction, High directly owns 186,291 shares, including 151,099 unvested RSUs.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a routine transaction for tax purposes.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Key Dates
| Date | Description |
|---|---|
| 11/15/2023 | Date of restricted stock unit grant |
| 03/07/2024 | Date of stock sale |
| 03/11/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.